Inamed Tissue Expander

Inamed is known for its technology innovations, customer focused solutions and its collaboration with doctors, nurses and all those connected with their subject. They are supposed to be the pioneers in medical device development for the benefit of both physicians and patients. Their initial focus was in breast aesthetics. They have a planning system, which provides guidance to patients and the doctors to find the best, and the right implants for breast characteristics. Inamed has manufacturing units in the United States, Ireland and Costa Rica and sells its products directly and through distributors in more than fifty countries.

Breast implant is done on patients for cosmetic purposes or for corrective purposes. And the tissue surrounding the implant expands when the saline or silica is injected into the device. Breast removal patients need breast reconstruction and implants form the major part of the procedures. Drooping or sagging breasts, unshapely ones also need implants and Inamed is one of the best names as manufacturers of breast implants devices. The shape of the tissue expander helps the doctor reconstruct the appearance of the breast and as Inamed has a wide variety; it is easy for the patient and the physician to choose the correct ones.

Inamed’s specialty is in breast implants and they come in a variety of shapes, textures and sizes. All the Inamed aesthetics implants have a self-sealing valve or diaphragm which is used for filling the device.  The filling valve may be located on the front or the back of the implant, depending on its style. For example, Style 68 is a round breast implant which has a smooth shell surface with an anterior filling valve and a moderate projection. Style 68LP also has a smooth shell surface and an anterior filling valve but with a low projection. Inamed has many styles to suit every patient.

Inamed has done follow ups in several surgeries and have found out that most women can expect to have one complication in five years after implant surgery. About three patients in ten may have an additional surgery after seven years.